International Career Development Exchange Call for Applications

Applications are open for the 2019 International Career Development Exchange which provides support for up-and-coming international surgical oncologists to attend the SSO Annual Cancer Symposium and visit a U.S. based institution following the meeting.  The 2019 International Career Development Exchange also includes a stipend to assist with travel arrangements, pairing the recipient with an SSO member mentor, a visit to the mentor’s institution for one week, and the opportunity to present an abstract poster at SSO2019. Get more information and download an application here.

Annals of Surgical Oncology: Celebrating 25 Years of Research and Education

Born from a vision to promote research and education and to advance the profession of surgical oncology, the Annals of Surgical Oncology (ASO) has become the journal of choice for surgical oncologists around the globe. Watch the video to learn more about the value of this prestigious publication.

ExpertED@SSO Launches the Robotic Approaches for GI Malignancies Series

Register Now for Molecular Testing of Indeterminate Thyroid Nodules

Mark your calendar for November 7, 2018 at 11:00 am EST for the new webinar, “Molecular Testing of Indeterminate Thyroid Nodules,” by Tracy S. Wang, MD, PhD. As management of indeterminate thyroid nodules evolves, the need for greater knowledge of testing options and cytological reporting increases. Participants in this webinar will be better able to discuss the Bethesda system for reporting thyroid cytology and not only identify molecular testing options, but also be able to determine optimal utilization of them.

Learn More About Current Controversies in Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

Register now for the new webinar, “Current Controversies in Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer,” on November 26, 2018 at 5:30 pm EST. Despite expert consensus that patients with localized but not clearly resettable pancreatic ductal adenocarcinoma (PDAC) should receive some form of neoadjuvant therapy, this intervention is not uniformly practiced. This webinar will identify the benefits of neoadjuvant therapy in patients with PDAC, compare options for neoadjuvant therapy and have a better understanding of how to assess current practices. Faculty for this program include Clifford Cho, MD, Theodore S. Hong, MD, Christina R. Ferrone, MD and Robert A. Wolff, MD.